Medically reviewed by Mary Choy, PharmD Mounjaro (tirzepatide) and Trulicity (dulaglutide) are prescription medications that help manage blood sugar levels in adults with type 2 diabetes.

The FDA approved two additional doses of the once-weekly GLP-1 receptor agonist dulaglutide, expanding the drug’s label to include 3 mg and 4.5 mg doses, according to an industry press release ...

TRULICITY is an injectable prescription medicine for adults with type 2 diabetes used to improve blood sugar (glucose) and used to reduce the risk of major cardiovascular events such as death ...

TRULICITY is an injectable prescription medicine for adults with type 2 diabetes used to improve blood sugar (glucose) and used to reduce the risk of major cardiovascular events such as death ...

Lannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH.

Food and Drug Administration today approved two additional doses of Eli Lilly and Company's Trulicity ®. "The FDA's decision to approve the additional doses of Trulicity is a positive step ...

European Commission Approves Trulicity® (dulaglutide) Solution for Injection, Lilly's Once-Weekly, Ready-to-Use Type 2 Diabetes Treatment By Jennifer Levin Nov 25, 2014 11:26am ...